Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Inflammation in atherosclerosis: pathophysiology and mechanisms
Atherosclerosis imposes a heavy burden on cardiovascular health due to its indispensable
role in the pathogenesis of cardiovascular disease (CVD) such as coronary artery disease …
role in the pathogenesis of cardiovascular disease (CVD) such as coronary artery disease …
NPM1‐mutated acute myeloid leukemia: New pathogenetic and therapeutic insights and open questions
B Falini - American journal of hematology, 2023 - Wiley Online Library
The nucleophosmin (NPM1) gene encodes for a multifunctional chaperone protein that is
localized in the nucleolus but continuously shuttles between the nucleus and cytoplasm …
localized in the nucleolus but continuously shuttles between the nucleus and cytoplasm …
[HTML][HTML] Acute myeloid leukemia
A Vakiti, SB Reynolds, P Mewawalla - StatPearls [Internet], 2024 - ncbi.nlm.nih.gov
Acute Myeloid Leukemia - StatPearls - NCBI Bookshelf US flag An official website of the United
States government Here's how you know NIH NLM Logo Access keys NCBI Homepage …
States government Here's how you know NIH NLM Logo Access keys NCBI Homepage …
Targeting of epigenetic co-dependencies enhances anti-AML efficacy of Menin inhibitor in AML with MLL1-r or mutant NPM1
W Fiskus, CP Mill, C Birdwell, JA Davis, K Das… - Blood cancer …, 2023 - nature.com
Monotherapy with Menin inhibitor (MI), eg, SNDX-5613, induces clinical remissions in
patients with relapsed/refractory AML harboring MLL1-r or mtNPM1, but most patients either …
patients with relapsed/refractory AML harboring MLL1-r or mtNPM1, but most patients either …
NPM 1 Mutations in AML—The Landscape in 2023
N Sharma, JL Liesveld - Cancers, 2023 - mdpi.com
Simple Summary The nucleophosmin 1 (NPM1) gene is mutated in approximately one-third
of newly diagnosed acute myeloid leukemia (AML) cases. NPM1mutated AML (NPM1 mut …
of newly diagnosed acute myeloid leukemia (AML) cases. NPM1mutated AML (NPM1 mut …
Practical considerations in clinical application of WHO 5th and ICC classification schemes for acute myeloid leukemia
The updated WHO 5th edition and ICC 2022 classification systems for AML aim to refine our
diagnostic criteria and definitions of AML with deeper incorporation of cytogenetic and …
diagnostic criteria and definitions of AML with deeper incorporation of cytogenetic and …
Biomarkers as targets for CAR-T/NK cell therapy in AML
R Shao, Z Li, H **n, S Jiang, Y Zhu, J Liu, R Huang… - Biomarker …, 2023 - Springer
The most common kind of acute leukemia in adults is acute myeloid leukemia (AML), which
is often treated with induction chemotherapy regimens followed by consolidation or …
is often treated with induction chemotherapy regimens followed by consolidation or …
Molecular landscape and validation of new genomic classification in 2668 adult AML patients: real life data from the PETHEMA registry
C Sargas, R Ayala, MJ Larráyoz, MC Chillón… - Cancers, 2023 - mdpi.com
Simple Summary Next–Generation Sequencing (NGS) has provided a deeper genetic
understanding of acute myeloid leukemia (AML) that has been recently incorporated into …
understanding of acute myeloid leukemia (AML) that has been recently incorporated into …
Targeting and Monitoring Acute Myeloid Leukaemia with Nucleophosmin-1 (NPM1) Mutation
L Chin, CYG Wong, H Gill - International Journal of Molecular Sciences, 2023 - mdpi.com
Mutations in NPM1, also known as nucleophosmin-1, B23, NO38, or numatrin, are seen in
approximately one-third of patients with acute myeloid leukaemia (AML). A plethora of …
approximately one-third of patients with acute myeloid leukaemia (AML). A plethora of …
Therapeutic targeting of the menin–KMT2A interaction
PR Freire, JA Cutler… - Annual Review of Cancer …, 2024 - annualreviews.org
The direct targeting of chromatin-associated proteins is increasingly recognized as a
potential therapeutic strategy for the treatment of cancer. In this review, we discuss a …
potential therapeutic strategy for the treatment of cancer. In this review, we discuss a …